The tumor area activated various proliferation and metastasis-related signaling pathways (such as MK, SPP1, SEMA3, MIF, and VEGF) and immunosuppression-related signaling pathway (GALECTIN) (Fig. 6D). Here, MIF is linked to neoplasm.